Status:

COMPLETED

Impact of tDCS on Cerebral Autoregulation

Lead Sponsor:

Charite University, Berlin, Germany

Conditions:

Cerebral Microangiopathy

CADASIL

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The aim of the study is to investigate whether there is a polarity-specific influence of tDCS on cerebral vasomotor reactivity monitored by transcranial doppler sonography.

Eligibility Criteria

Inclusion

  • severe cerebral Microangiopathy
  • NOTCH3 carrier
  • Migraine with aura (IHS Classification ICHD-II)
  • Stenosis \>80%, ECST-Criteria

Exclusion

  • seizure disorder
  • history of severe alcohol or drug abuse, psychiatric illness like severe depression, poor motivational capacity
  • dementia
  • (1+2) history of stroke in past 3 months (3) migraine prophylaxis (4) contralateral stenosis \>50%,

Key Trial Info

Start Date :

April 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2014

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01865604

Start Date

April 1 2012

End Date

March 1 2014

Last Update

March 16 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology, Charité Universitätsmedizin Berlin

Berlin, State of Berlin, Germany, 10117

Impact of tDCS on Cerebral Autoregulation | DecenTrialz